Predicted Trait | |
Reported Trait | Basal cell carcinoma |
Mapped Trait(s) | basal cell carcinoma (EFO_0004193) |
Score Construction | |
PGS Name | UKBPRS |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | p<1e-04 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 273 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000429 |
Citation (link to publication) | Seviiri M et al. Nat Commun (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 307,684 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
— | [
|
European | UKB |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM017070 | PSS010113| European Ancestry| 18,933 individuals |
PGP000429 | Seviiri M et al. Nat Commun (2022) |
Reported Trait: Keratinocyte cancers | OR: 1.56 [1.45, 1.67] | — | — | age, sex, 10 ancesty PCs | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010113 | — | — | 18,933 individuals | — | European | — | CLSA | — |